Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00596843 · ClinicalTrials.gov registry record · Phase 3
Chronic Hepatitis Intervention Project for Drug Users
A Phase 3 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 3
- Development phase
- 851
- Enrollment target
NCT00596843: Completed Phase 3 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00596843 is a Phase 3 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 851 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (10% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00596843, a Phase 3 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 851 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a 6-session motivational interviewing intervention is more effective than a 6-session educational intervention at reducing behaviors that may lead to infection, transmission, and progression of HIV and hepatitis C among out of treatment injecting drug users.
Interventions
- BEHAVIORAL Motivational interviewing
- BEHAVIORAL Educational intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 851 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-11 |
| Phase | Phase 3 |
What the finished NCT00596843 record still lists
NCT00596843 is an interventional study that assigns participants to a tested intervention. The registered 851 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (10% higher).
The record links to 0 conditions, and to 2 interventions - of which Motivational interviewing is the first listed.
NCT00596843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00596843 about?
NCT00596843 is a clinical study titled "Chronic Hepatitis Intervention Project for Drug Users". The purpose of this study is to determine if a 6-session motivational interviewing intervention is more effective than a 6-session educational intervention at reducing behaviors that may lead to infection, transmission, and progression of HIV and hepatitis C among out of treatment injecting drug use...
What is the current status of trial NCT00596843?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 851 participants. The study started on 2003-09. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00596843?
The interventions under investigation include: Motivational interviewing (BEHAVIORAL), Educational intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00596843?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00596843's enrollment target sits among peer trials
851 386th of 2000 higher than 1,614 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06422143 · 851 participants · Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- NCT06237452 · 852 participants · Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia